NAVCO Pharmaceuticals Inc (NAV) Stock Statistics & Valuation Metrics

NAVCO Pharmaceuticals Inc has a market cap or net worth of CAD 285.35K. The enterprise value is CAD 381.56K.

Market Cap

CAD 285.35K

Enterprise Value

CAD 381.56K

NAVCO Pharmaceuticals Inc has 57,069,542 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

57,069,542

Owned by Insiders

―

Owned by Institutions

―

NAVCO Pharmaceuticals Inc’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)

―

Return on Assets (ROA)

―

Return on Invested Capital (ROIC)

―

Return on Capital Employed (ROCE)

―

Revenue Per Employee

―

Profits Per Employee

―

Employee Count

0

Asset Turnover

―

Inventory Turnover

―

In the last 12 months, NAVCO Pharmaceuticals Inc had revenue of ― and earned 0 in profits. Earnings per share was ―.

Revenue

―

Gross Profit

―

Operating Income

0

Pretax Income

―

Net Income

0

EBITDA

0

Earnings Per Share (EPS)

―

Beta

-1.14

52-Week Price Change

0.00%

50-Day Moving Average

0.01

200-Day Moving Average

0.01

Relative Strength Index (RSI)

―

Average Volume (3m)

―

NAVCO Pharmaceuticals Inc upcoming earnings date is Mar 08, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 27, 2026

Next Earnings Date

Mar 08, 2027

Ex-Dividend Date

―

NAVCO Pharmaceuticals Inc has ― in cash and marketable securities with CAD 0.00 in debt, giving a net cash position of ― billion.

Cash & Marketable Securities

―

Total Debt

CAD 0.00

Net Cash

―

Net Cash Per Share

―

Tangible Book Value Per Share

―

The average price target for NAVCO Pharmaceuticals Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

0

Revenue Growth Forecast

―

EPS Growth Forecast

92.55%